TANYA CASTOR: Open Payments
NPI 1326130451 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,517 in 74 payments from 14 companies in 2025. Trend: 2023 $598 · 2024 $661 · 2025 $1,517
Food & beverage: $1,367Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $217 |
| AstraZeneca Pharmaceuticals LP | 9 | $204 |
| Grifols USA, LLC | 7 | $202 |
| GlaxoSmithKline, LLC. | 13 | $183 |
| Amgen Inc. | 11 | $169 |
| JAZZ PHARMACEUTICALS INC. | 1 | $150 |
| Insmed, Inc. | 5 | $76 |
| Philips North America LLC | 3 | $71 |
| GENZYME CORPORATION | 3 | $61 |
| Abbott Laboratories | 1 | $60 |
Products named: DUPIXENT, Prolastin-C Liquid, TEZSPIRE, XYWAV, NUCALA, AIRSUPRA, FASENRA, Arikayce.
Industry payments across KS — which companies pay providers there.
